Spectaire (SPEC) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends SPEC vs. HTGMQ, OLITW, PRENW, QSIAW, SMAPW, THMO, TT, KEYS, FTV, and VLTOShould you be buying Spectaire stock or one of its competitors? The main competitors of Spectaire include HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), ThermoGenesis (THMO), Trane Technologies (TT), Keysight Technologies (KEYS), Fortive (FTV), and Veralto (VLTO). These companies are all part of the "measuring and control equipment" industry. Spectaire vs. HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition ThermoGenesis Trane Technologies Keysight Technologies Fortive Veralto Spectaire (NASDAQ:SPEC) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, community ranking, valuation and earnings. Which has more volatility and risk, SPEC or HTGMQ? Spectaire has a beta of -0.56, suggesting that its share price is 156% less volatile than the S&P 500. Comparatively, HTG Molecular Diagnostics has a beta of 2.57, suggesting that its share price is 157% more volatile than the S&P 500. Does the media refer more to SPEC or HTGMQ? In the previous week, Spectaire's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score. Company Overall Sentiment Spectaire Neutral HTG Molecular Diagnostics Neutral Which has better earnings and valuation, SPEC or HTGMQ? Spectaire has higher earnings, but lower revenue than HTG Molecular Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectaireN/AN/A$8.95MN/AN/AHTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A Is SPEC or HTGMQ more profitable? HTG Molecular Diagnostics' return on equity of 0.00% beat Spectaire's return on equity.Company Net Margins Return on Equity Return on Assets SpectaireN/A -81.22% 304.57% HTG Molecular Diagnostics N/A N/A N/A Do insiders and institutionals believe in SPEC or HTGMQ? 26.6% of Spectaire shares are held by institutional investors. 25.4% of Spectaire shares are held by insiders. Comparatively, 2.6% of HTG Molecular Diagnostics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community believe in SPEC or HTGMQ? Spectaire and HTG Molecular Diagnostics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformSpectaireOutperform VotesNo VotesUnderperform Votes1100.00% HTG Molecular DiagnosticsN/AN/A SummarySpectaire beats HTG Molecular Diagnostics on 4 of the 7 factors compared between the two stocks. Get Spectaire News Delivered to You Automatically Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPEC vs. The Competition Export to ExcelMetricSpectaireMeasuring & controlling devices IndustryComputer SectorNASDAQ ExchangeMarket CapN/A$20.59B$26.22B$8.98BDividend YieldN/A3.22%2.74%3.85%P/E RatioN/A21.4646.3418.82Price / SalesN/A15.032,532.9680.40Price / CashN/A17.5635.5737.47Price / BookN/A2.886.864.64Net Income$8.95M$579.38M$731.18M$245.69M Spectaire Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPECSpectaireN/AN/AN/AN/A$2,000.00N/A0.008HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.08+2.4%N/A-18.3%$0.00N/A0.003Gap UpPRENWPrenetics GlobalN/A$0.01+34.2%N/A+66.7%$0.00$25.56M0.001Negative NewsGap DownQSIAWQuantum-SiN/A$0.80+6.7%N/A+220.3%$0.00$2.27M0.00150Negative NewsSMAPWSportsMap Tech AcquisitionN/A$0.05flatN/AN/A$0.00N/A0.00N/AGap UpTHMOThermoGenesisN/A$0.00flatN/AN/A$0.00$9.44M0.0040News CoverageTTTrane Technologies4.4163 of 5 stars$360.23+1.1%$415.25+15.3%+28.3%$80.49B$19.84B32.0240,000Analyst RevisionPositive NewsKEYSKeysight Technologies3.9563 of 5 stars$177.32+1.7%$180.80+2.0%+21.7%$30.71B$4.98B50.6615,500Upcoming EarningsAnalyst UpgradePositive NewsFTVFortive4.4848 of 5 stars$80.54+1.8%$87.64+8.8%-5.2%$27.70B$6.07B32.0918,000Positive NewsVLTOVeralto3.6126 of 5 stars$99.88+1.1%$112.55+12.7%+15.1%$24.34B$5.19B29.9016,000News CoveragePositive News Related Companies and Tools Related Companies HTGMQ Alternatives OLITW Alternatives PRENW Alternatives QSIAW Alternatives SMAPW Alternatives THMO Alternatives TT Alternatives KEYS Alternatives FTV Alternatives VLTO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SPEC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectaire Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectaire With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SPEC Stock Alerts